Skip to main content
Erschienen in: Inflammation 3/2018

29.01.2018 | ORIGINAL ARTICLE

Effects of Diet-Induced Obesity on Tracheal Responsiveness to Methacholine, Tracheal Visfatin Level, and Lung Histological Changes in Ovalbumin-Sensitized Female Wistar Rats

verfasst von: Rana Keyhanmanesh, Mohammad Reza Alipour, Hadi Ebrahimi, Mohammad Reza Aslani

Erschienen in: Inflammation | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Many studies have shown a close relationship between obesity and asthma severity. In the present study, the effects of diet-induced obesity were examined on airway responsiveness to methacholine in addition to visfatin level in female Wistar rats’ tracheae after sensitization with ovalbumin. The rats were divided into four groups: control with normal diet (ND), ovalbumin (OVA)-sensitized with normal diet (S + ND), high-fat diet (HFD), and OVA-sensitized with a high-fat diet (S + HFD). The animals were fed for 8 weeks with standard pelts or high-fat diet and then sensitized and challenged with OVA or saline for another 4 weeks. At the end of the study, the tracheae were isolated and assessed for airway responsiveness and visfatin protein levels. Diet-induced obesity groups developed increased weight and obesity indices (p < 0.001). After sensitization with OVA and diet-induced obesity, there were marked leftward shifts in methacholine concentration-response curves in S + HFD group compared to other groups. Also, maximum response was the highest (p < 0.05 to p < 0.001), EC50 was the lowest (p < 0.05 to p < 0.001), and visfatin protein level was the highest (p < 0.05 to p < 0.01) in S + HFD. According to results, diet-induced obesity caused airway hyperresponsiveness to methacholine and enhanced visfatin protein levels in the tracheae of ovalbumin-sensitized female rats. Our results suggested that, in obese ovalbumin-sensitized conditions in female rats, the local production of adipocytokines, such as visfatin, may be increased, resulting in the deterioration of inflammation in lungs. This finding shows a possible mechanism for the altered phenotype in obesity-ovalbumin sensitization conditions in female rats.
Literatur
1.
Zurück zum Zitat Beuther, D.A., S.T. Weiss, and E.R. Sutherland. 2006. Obesity and asthma. American Journal of Respiratory and Critical Care Medicine 2: 112–119.CrossRef Beuther, D.A., S.T. Weiss, and E.R. Sutherland. 2006. Obesity and asthma. American Journal of Respiratory and Critical Care Medicine 2: 112–119.CrossRef
2.
Zurück zum Zitat Akerman, M.J., C.M. Calacanis, and M.K. Madsen. 2004. Relationship between asthma severity and obesity. Journal of Asthma 5: 521–526.CrossRef Akerman, M.J., C.M. Calacanis, and M.K. Madsen. 2004. Relationship between asthma severity and obesity. Journal of Asthma 5: 521–526.CrossRef
3.
Zurück zum Zitat Johnston, R.A., T.A. Theman, and S.A. Shore. 2006. Augmented responses to ozone in obese carboxypeptidase E-deficient mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 1: R126–R133.CrossRef Johnston, R.A., T.A. Theman, and S.A. Shore. 2006. Augmented responses to ozone in obese carboxypeptidase E-deficient mice. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 1: R126–R133.CrossRef
4.
Zurück zum Zitat Saadat, S., M. Mohammadi, M. Fallahi, and M.R. Aslani. 2015. The protective effect of α-hederin, the active constituent of Nigella sativa, on tracheal responsiveness and lung inflammation in ovalbumin-sensitized guinea pigs. The Journal of Physiological Sciences 3: 285–292.CrossRef Saadat, S., M. Mohammadi, M. Fallahi, and M.R. Aslani. 2015. The protective effect of α-hederin, the active constituent of Nigella sativa, on tracheal responsiveness and lung inflammation in ovalbumin-sensitized guinea pigs. The Journal of Physiological Sciences 3: 285–292.CrossRef
5.
Zurück zum Zitat Aslani, M.R., R. Keyhanmanesh, A.M. Khamaneh, M.M. Abbasi, M. Fallahi, and M.R. Alipour. 2016. Tracheal overexpression of IL-1β, IRAK-1 and TRAF-6 mRNA in obese-asthmatic male Wistar rats. Iranian Journal of Basic Medical Sciences 4: 350–357. Aslani, M.R., R. Keyhanmanesh, A.M. Khamaneh, M.M. Abbasi, M. Fallahi, and M.R. Alipour. 2016. Tracheal overexpression of IL-1β, IRAK-1 and TRAF-6 mRNA in obese-asthmatic male Wistar rats. Iranian Journal of Basic Medical Sciences 4: 350–357.
6.
Zurück zum Zitat Wellen, K.E., and G.S. Hotamisligil. 2005. Inflammation, stress, and diabetes. Journal of Clinical Investigation 5: 1111.CrossRef Wellen, K.E., and G.S. Hotamisligil. 2005. Inflammation, stress, and diabetes. Journal of Clinical Investigation 5: 1111.CrossRef
7.
Zurück zum Zitat Tilg, H., and A.R. Moschen. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 10: 772–783.CrossRef Tilg, H., and A.R. Moschen. 2006. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 10: 772–783.CrossRef
8.
Zurück zum Zitat Medoff, B.D., Y. Okamoto, P. Leyton, M. Weng, B.P. Sandall, M.J. Raher, et al. 2009. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. American Journal of Respiratory Cell and Molecular Biology 4: 397–406.CrossRef Medoff, B.D., Y. Okamoto, P. Leyton, M. Weng, B.P. Sandall, M.J. Raher, et al. 2009. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. American Journal of Respiratory Cell and Molecular Biology 4: 397–406.CrossRef
9.
Zurück zum Zitat Assad, N.A., and A. Sood. 2012. Leptin, adiponectin and pulmonary diseases. Biochimie 10: 2180–2189.CrossRef Assad, N.A., and A. Sood. 2012. Leptin, adiponectin and pulmonary diseases. Biochimie 10: 2180–2189.CrossRef
10.
Zurück zum Zitat Aslani, M.R., R. Keyhanmanesh, and M.R. Alipour. 2017. Increased visfatin expression is associated with nuclear factor-κB in obese ovalbumin-sensitized male Wistar rat tracheae. Medical Principles and Practice 26: 351–358.CrossRefPubMedPubMedCentral Aslani, M.R., R. Keyhanmanesh, and M.R. Alipour. 2017. Increased visfatin expression is associated with nuclear factor-κB in obese ovalbumin-sensitized male Wistar rat tracheae. Medical Principles and Practice 26: 351–358.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Samal, B., Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece. 1994. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 2: 1431–1437.CrossRef Samal, B., Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece. 1994. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 2: 1431–1437.CrossRef
12.
Zurück zum Zitat Adeghate, E. 2008. Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Current Medicinal Chemistry 18: 1851–1862.CrossRef Adeghate, E. 2008. Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Current Medicinal Chemistry 18: 1851–1862.CrossRef
13.
Zurück zum Zitat Friebe, D., M. Neef, J. Kratzsch, S. Erbs, K. Dittrich, A. Garten, et al. 2011. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 5: 1200–1211.CrossRef Friebe, D., M. Neef, J. Kratzsch, S. Erbs, K. Dittrich, A. Garten, et al. 2011. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 5: 1200–1211.CrossRef
14.
Zurück zum Zitat Luk, T., Z. Malam, and J.C. Marshall. 2008. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. Journal of Leukocyte Biology 4: 804–816.CrossRef Luk, T., Z. Malam, and J.C. Marshall. 2008. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. Journal of Leukocyte Biology 4: 804–816.CrossRef
15.
Zurück zum Zitat Ye, S.Q., B.A. Simon, J.P. Maloney, A. Zambelli-Weiner, L. Gao, A. Grant, et al. 2005. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. American Journal of Respiratory and Critical Care Medicine 4: 361–370.CrossRef Ye, S.Q., B.A. Simon, J.P. Maloney, A. Zambelli-Weiner, L. Gao, A. Grant, et al. 2005. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. American Journal of Respiratory and Critical Care Medicine 4: 361–370.CrossRef
16.
Zurück zum Zitat Bekyürek, T., N. Liman, and G. Bayram. 2002. Diagnosis of sexual cycle by means of vaginal smear method in the chinchilla (Chinchilla lanigera). Laboratory Animals 1: 51–60.CrossRef Bekyürek, T., N. Liman, and G. Bayram. 2002. Diagnosis of sexual cycle by means of vaginal smear method in the chinchilla (Chinchilla lanigera). Laboratory Animals 1: 51–60.CrossRef
17.
Zurück zum Zitat Beuther, D.A., and E.R. Sutherland. 2007. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. American Journal of Respiratory and Critical Care Medicine 7: 661–666.CrossRef Beuther, D.A., and E.R. Sutherland. 2007. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. American Journal of Respiratory and Critical Care Medicine 7: 661–666.CrossRef
18.
Zurück zum Zitat Ahmadi, M., R. Rahbarghazi, M.R. Aslani, A.-A. Shahbazfar, M. Kazemi, and R. Keyhanmanesh. 2017. Bone marrow mesenchymal stem cells and their conditioned media could potentially ameliorate ovalbumin-induced asthmatic changes. Biomedicine & Pharmacotherapy 85: 28–40.CrossRef Ahmadi, M., R. Rahbarghazi, M.R. Aslani, A.-A. Shahbazfar, M. Kazemi, and R. Keyhanmanesh. 2017. Bone marrow mesenchymal stem cells and their conditioned media could potentially ameliorate ovalbumin-induced asthmatic changes. Biomedicine & Pharmacotherapy 85: 28–40.CrossRef
19.
Zurück zum Zitat Aslani, M.R., R. Keyhanmanesh, A.M. Khamaneh, M.A. Ebrahimi Saadatlou, M.M. Abbasi, and M.R. Alipour. 2016. Lung altered expression of IL-1β mRNA and its signaling pathway molecules in obese-asthmatic male Wistar rats. Iranian Journal of Allergy, Asthma and Immunology 3: 183–197. Aslani, M.R., R. Keyhanmanesh, A.M. Khamaneh, M.A. Ebrahimi Saadatlou, M.M. Abbasi, and M.R. Alipour. 2016. Lung altered expression of IL-1β mRNA and its signaling pathway molecules in obese-asthmatic male Wistar rats. Iranian Journal of Allergy, Asthma and Immunology 3: 183–197.
20.
Zurück zum Zitat Shore, S.A. 2007. Obesity and asthma: lessons from animal models. Journal of Applied Physiology 2: 516–528.CrossRef Shore, S.A. 2007. Obesity and asthma: lessons from animal models. Journal of Applied Physiology 2: 516–528.CrossRef
21.
Zurück zum Zitat Shore, S.A., Y.M. Rivera-Sanchez, I.N. Schwartzman, and R.A. Johnston. 2003. Responses to ozone are increased in obese mice. Journal of Applied Physiology 3: 938–945.CrossRef Shore, S.A., Y.M. Rivera-Sanchez, I.N. Schwartzman, and R.A. Johnston. 2003. Responses to ozone are increased in obese mice. Journal of Applied Physiology 3: 938–945.CrossRef
22.
Zurück zum Zitat Xisto, D.G., L.L. Farias, H.C. Ferreira, M.R. Picanço, D. Amitrano, J.R. Lapa e Silva, et al. 2005. Lung parenchyma remodeling in a murine model of chronic allergic inflammation. American Journal of Respiratory and Critical Care Medicine 8: 829–837.CrossRef Xisto, D.G., L.L. Farias, H.C. Ferreira, M.R. Picanço, D. Amitrano, J.R. Lapa e Silva, et al. 2005. Lung parenchyma remodeling in a murine model of chronic allergic inflammation. American Journal of Respiratory and Critical Care Medicine 8: 829–837.CrossRef
23.
Zurück zum Zitat Johnston, R.A., M. Zhu, Y.M. Rivera-Sanchez, F.L. Lu, T.A. Theman, L. Flynt, et al. 2007. Allergic airway responses in obese mice. American Journal of Respiratory and Critical Care Medicine 7: 650–658.CrossRef Johnston, R.A., M. Zhu, Y.M. Rivera-Sanchez, F.L. Lu, T.A. Theman, L. Flynt, et al. 2007. Allergic airway responses in obese mice. American Journal of Respiratory and Critical Care Medicine 7: 650–658.CrossRef
24.
Zurück zum Zitat Lu, F.L., R.A. Johnston, L. Flynt, T.A. Theman, R.D. Terry, I.N. Schwartzman, et al. 2006. Increased pulmonary responses to acute ozone exposure in obese db/db mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 5: L856–L865.CrossRef Lu, F.L., R.A. Johnston, L. Flynt, T.A. Theman, R.D. Terry, I.N. Schwartzman, et al. 2006. Increased pulmonary responses to acute ozone exposure in obese db/db mice. American Journal of Physiology-Lung Cellular and Molecular Physiology 5: L856–L865.CrossRef
25.
Zurück zum Zitat Dixon, A.E., and E.M. Clerisme-Beaty. 2013. Obesity and lung disease: a guide to management. New York: Humana Press. Dixon, A.E., and E.M. Clerisme-Beaty. 2013. Obesity and lung disease: a guide to management. New York: Humana Press.
26.
Zurück zum Zitat Ahmadi, M., R. Rahbarghazi, S. Soltani, M.R. Aslani, and R. Keyhanmanesh. 2016. Contributory anti-inflammatory effects of mesenchymal stem cells, not conditioned media, on ovalbumin-induced asthmatic changes in male rats. Inflammation 6: 1960–1971.CrossRef Ahmadi, M., R. Rahbarghazi, S. Soltani, M.R. Aslani, and R. Keyhanmanesh. 2016. Contributory anti-inflammatory effects of mesenchymal stem cells, not conditioned media, on ovalbumin-induced asthmatic changes in male rats. Inflammation 6: 1960–1971.CrossRef
27.
Zurück zum Zitat Hogan, S.P., H.F. Rosenberg, R. Moqbel, S. Phipps, P.S. Foster, P. Lacy, et al. 2008. Eosinophils: biological properties and role in health and disease. Clinical & Experimental Allergy 5: 709–750.CrossRef Hogan, S.P., H.F. Rosenberg, R. Moqbel, S. Phipps, P.S. Foster, P. Lacy, et al. 2008. Eosinophils: biological properties and role in health and disease. Clinical & Experimental Allergy 5: 709–750.CrossRef
28.
Zurück zum Zitat Calixto, M., L. Lintomen, A. Schenka, M. Saad, A. Zanesco, and E. Antunes. 2010. Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. British Journal of Pharmacology 3: 617–625.CrossRef Calixto, M., L. Lintomen, A. Schenka, M. Saad, A. Zanesco, and E. Antunes. 2010. Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. British Journal of Pharmacology 3: 617–625.CrossRef
29.
Zurück zum Zitat Teramoto, S., H. Yamamoto, and Y. Ouchi. 2003. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 5: e40–e40.CrossRef Teramoto, S., H. Yamamoto, and Y. Ouchi. 2003. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 5: e40–e40.CrossRef
30.
Zurück zum Zitat Vozarova, B., C. Weyer, K. Hanson, P.A. Tataranni, C. Bogardus, and R.E. Pratley. 2001. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research 7: 414–417.CrossRef Vozarova, B., C. Weyer, K. Hanson, P.A. Tataranni, C. Bogardus, and R.E. Pratley. 2001. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research 7: 414–417.CrossRef
31.
Zurück zum Zitat Shore, S.A. 2008. Obesity and asthma: possible mechanisms. Journal of Allergy and Clinical Immunology 5: 1087–1093.CrossRef Shore, S.A. 2008. Obesity and asthma: possible mechanisms. Journal of Allergy and Clinical Immunology 5: 1087–1093.CrossRef
32.
Zurück zum Zitat Nowell, M.A., P.J. Richards, C.A. Fielding, S. Ognjanovic, N. Topley, A.S. Williams, et al. 2006. Regulation of pre-B cell colony-enhancing factor by STAT-3–dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism 7: 2084–2095.CrossRef Nowell, M.A., P.J. Richards, C.A. Fielding, S. Ognjanovic, N. Topley, A.S. Williams, et al. 2006. Regulation of pre-B cell colony-enhancing factor by STAT-3–dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism 7: 2084–2095.CrossRef
33.
Zurück zum Zitat Chen, M.-P., F.-M. Chung, D.-M. Chang, J.C.-R. Tsai, H.-F. Huang, S.-J. Shin, et al. 2006. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism 1: 295–299.CrossRef Chen, M.-P., F.-M. Chung, D.-M. Chang, J.C.-R. Tsai, H.-F. Huang, S.-J. Shin, et al. 2006. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism 1: 295–299.CrossRef
34.
Zurück zum Zitat Moschen, A.R., A. Kaser, B. Enrich, B. Mosheimer, M. Theurl, H. Niederegger, et al. 2007. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. The Journal of Immunology 3: 1748–1758.CrossRef Moschen, A.R., A. Kaser, B. Enrich, B. Mosheimer, M. Theurl, H. Niederegger, et al. 2007. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. The Journal of Immunology 3: 1748–1758.CrossRef
35.
Zurück zum Zitat Jia, S.H., Y. Li, J. Parodo, A. Kapus, L. Fan, O.D. Rotstein, et al. 2004. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation 9: 1318.CrossRef Jia, S.H., Y. Li, J. Parodo, A. Kapus, L. Fan, O.D. Rotstein, et al. 2004. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. Journal of Clinical Investigation 9: 1318.CrossRef
36.
Zurück zum Zitat Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, et al. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 3: 315–325.CrossRef Romano, M., M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, et al. 1997. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 3: 315–325.CrossRef
Metadaten
Titel
Effects of Diet-Induced Obesity on Tracheal Responsiveness to Methacholine, Tracheal Visfatin Level, and Lung Histological Changes in Ovalbumin-Sensitized Female Wistar Rats
verfasst von
Rana Keyhanmanesh
Mohammad Reza Alipour
Hadi Ebrahimi
Mohammad Reza Aslani
Publikationsdatum
29.01.2018
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-018-0738-2

Weitere Artikel der Ausgabe 3/2018

Inflammation 3/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Krebspatienten impfen: Was? Wen? Und wann nicht?

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Nierenultraschall: Tipps vom Profi

22.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

„KI sieht, was wir nicht sehen“

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.